(Q46553515)

23 December 2017

title

Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer (English)

1 reference

23 December 2017

3

Eero Pukkala

1 reference

23 December 2017

2

Jaakko Tuomilehto

1 reference

23 December 2017

6

Erkki Vartiainen

1 reference

23 December 2017

Pekka Jousilahti

7

object named as

Pekka Jousilahti

1 reference

23 December 2017

author name string

Gang Hu

1

1 reference

23 December 2017

Timo Hakulinen

4

1 reference

23 December 2017

Riitta Antikainen

5

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 July 2008

1 reference

23 December 2017

published in

Hepatology

1 reference

23 December 2017

volume

48

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

129-136

1 reference

23 December 2017

Serum tumor markers for detection of hepatocellular carcinoma

cites work

1 reference

Global epidemiology of hepatitis C virus infection

21 January 2018

1 reference

7 January 2021

Hepatitis B virus infection: epidemiology and vaccination

1 reference

7 January 2021

Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.

1 reference

7 January 2021

Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan

1 reference

7 January 2021

Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan

1 reference

7 January 2021

Coffee Consumption and Risk of Liver Cancer: A Meta-Analysis

1 reference

7 January 2021

Coffee drinking and hepatocellular carcinoma risk: a meta-analysis.

1 reference

7 January 2021

Unexpected effects of coffee consumption on liver enzymes.

1 reference

7 January 2021

Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers

1 reference

7 January 2021

Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States

1 reference

7 January 2021

Alcohol, smoking, coffee, and cirrhosis

1 reference

7 January 2021

Coffee, caffeine, and the risk of liver cirrhosis

1 reference

7 January 2021

Gamma glutamyl transferase

1 reference

7 January 2021

Cardiovascular risk factor changes in Finland, 1972-1997

1 reference

7 January 2021

Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women

1 reference

7 January 2021

Coffee consumption and the incidence of antihypertensive drug treatment in Finnish men and women

1 reference

7 January 2021

Validity of a food frequency questionnaire varied by age and body mass index.

1 reference

7 January 2021

Data quality and quality control of a population-based cancer registry. Experience in Finland

1 reference

7 January 2021

Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future

1 reference

7 January 2021

Coffee and tea consumption and risk of hepatocellular carcinoma in Italy

1 reference

7 January 2021

Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation

1 reference

7 January 2021

Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes

1 reference

7 January 2021

Liver cirrhosis and the risk of primary liver cancer.

1 reference

7 January 2021

Suppressive effect of coffee on lipopolysaccharide-induced hepatitis in D-galactosamine-sensitized rats

1 reference

7 January 2021

gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women

1 reference

7 January 2021

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22320

1 reference

23 December 2017

PubMed ID

18537182

1 reference

23 December 2017